InnoCan Pharma INNPF Stock
InnoCan Pharma Price Chart
InnoCan Pharma INNPF Financial and Trading Overview
| InnoCan Pharma stock price | 0.23 USD |
| Previous Close | 0.19 USD |
| Open | 0.19 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.19 - 0.19 USD |
| 52 Week Range | 0.14 - 0.44 USD |
| Volume | 300 USD |
| Avg. Volume | 281 USD |
| Market Cap | 49.17M USD |
| Beta (5Y Monthly) | 3.505608 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
INNPF Valuation Measures
| Enterprise Value | 42.9M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 12.740569 |
| Price/Book (mrq) | 8.5 |
| Enterprise Value/Revenue | 11.116 |
| Enterprise Value/EBITDA | -7.547 |
Trading Information
InnoCan Pharma Stock Price History
| Beta (5Y Monthly) | 3.505608 |
| 52-Week Change | -57.11% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.44 USD |
| 52 Week Low | 0.14 USD |
| 50-Day Moving Average | 0.16 USD |
| 200-Day Moving Average | 0.21 USD |
INNPF Share Statistics
| Avg. Volume (3 month) | 281 USD |
| Avg. Daily Volume (10-Days) | 30 USD |
| Shares Outstanding | 251.81M |
| Float | 225.63M |
| Short Ratio | N/A |
| % Held by Insiders | 28.43% |
| % Held by Institutions | 0.21% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -113.57% |
| Operating Margin (ttm) | -148.044% |
| Gross Margin | 88.07% |
| EBITDA Margin | -147.29% |
Management Effectiveness
| Return on Assets (ttm) | -40.38% |
| Return on Equity (ttm) | -62.31% |
Income Statement
| Revenue (ttm) | 3.86M USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | 500.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -5684000 USD |
| Net Income Avi to Common (ttm) | -4383000 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.09M USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 26K USD |
| Total Debt/Equity (mrq) | 0.49 USD |
| Current Ratio (mrq) | 6.057 |
| Book Value Per Share (mrq) | 0.022 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5651000 USD |
| Levered Free Cash Flow (ttm) | -4956875 USD |
Profile of InnoCan Pharma
| Country | United States |
| State | AB |
| City | Calgary |
| Address | 1015, 926 – 5 Avenue SW |
| ZIP | T2P 0N7 |
| Phone | 403-777-1519 |
| Website | https://innocanpharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. It engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes to pain relief and treatment of epilepsy and other central nervous system disorders and other indications. The company offers its products under the Shir and Relief & Go brand names. It is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The company was incorporated in 2018 and is headquartered in Calgary, Canada.
Q&A For InnoCan Pharma Stock
What is a current INNPF stock price?
InnoCan Pharma INNPF stock price today per share is 0.23 USD.
How to purchase InnoCan Pharma stock?
You can buy INNPF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for InnoCan Pharma?
The stock symbol or ticker of InnoCan Pharma is INNPF.
Which industry does the InnoCan Pharma company belong to?
The InnoCan Pharma industry is Drug Manufacturers-Specialty & Generic.
How many shares does InnoCan Pharma have in circulation?
The max supply of InnoCan Pharma shares is 280.66M.
What is InnoCan Pharma Price to Earnings Ratio (PE Ratio)?
InnoCan Pharma PE Ratio is now.
What was InnoCan Pharma earnings per share over the trailing 12 months (TTM)?
InnoCan Pharma EPS is -0.02 USD over the trailing 12 months.
Which sector does the InnoCan Pharma company belong to?
The InnoCan Pharma sector is Healthcare.